Authors: Strikoudis, Alexandros; Cieślak, Anna; Loffredo, Lucas; Chen, Ya-Wen; Patel, Nina; Saqi, Anjali; Lederer, David J.; Snoeck, Hans-Willem
Online: https://linkinghub.elsevier.com/retrieve/pii/S2211124719307065
Issue: Cell Rep. 2019 Jun 18;27(12):3709-3723.e5.
Abstract
The pathogenesis of idiopathic pulmonary fibrosis (IPF), an intractable interstitial lung disease, is unclear. Recessive mutations in some genes implicated in Hermansky-Pudlak syndrome (HPS) cause HPS-associated interstitial pneumonia (HPSIP), a clinical entity that is similar to IPF. We previously reported that HPS1-/- embryonic stem cell-derived 3D lung organoids showed fibrotic changes. Here, we show that the introduction of all HPS mutations associated with HPSIP promotes fibrotic changes in lung organoids, while the deletion of HPS8, which is not associated with HPSIP, does not. Genome-wide expression analysis revealed the upregulation of interleukin-11 (IL-11) in epithelial cells from HPS mutant fibrotic organoids. IL-11 was detected predominantly in type 2 alveolar epithelial cells in end-stage IPF, but was expressed more broadly in HPSIP. Finally, IL-11 induced fibrosis in WT organoids, while its deletion prevented fibrosis in HPS4-/- organoids, suggesting IL-11 as a therapeutic target. hPSC-derived 3D lung organoids are, therefore, a valuable resource to model fibrotic lung disease. Keywords: Hermansky-Pudlak syndrome; disease modeling; human pluripotent stem cells; interleukin-11; lung; organoids; pulmonary fibrosis.
